Brixton Biosciences, Inc.

This study tests a device called ReneuRx™ that targets specific nerves to reduce chronic lateral hip pain. About 100 adults aged 22-80 with moderate to severe pain will either get the device treatment or a standard steroid injection. Researchers will track pain levels and quality…